MHRA authorises first oral GLP-1 therapy for weight management
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the first glucagon-like peptide-1 (GLP-1) receptor agonist weight-loss tablet for use in the UK. The once-daily semaglutide tablet, marketed by